171 related articles for article (PubMed ID: 17703294)
1. Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent implantation.
Qian J; Zhang F; Wu H; Fan B; Ge L; Ge J
Int J Cardiovasc Imaging; 2008 Feb; 24(2):133-9. PubMed ID: 17703294
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis.
Degertekin M; Serruys PW; Tanabe K; Lee CH; Sousa JE; Colombo A; Morice MC; Ligthart JM; de Feyter PJ
Circulation; 2003 Dec; 108(22):2747-50. PubMed ID: 14638542
[TBL] [Abstract][Full Text] [Related]
3. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
[TBL] [Abstract][Full Text] [Related]
4. Risk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials.
Sanchez-Recalde A; Moreno R; Barreales L; Rivero F; Galeote G; Jimenez-Valero S; Calvo L; López de Sá E; López-Sendón JL
J Invasive Cardiol; 2008 Aug; 20(8):417-22. PubMed ID: 18688067
[TBL] [Abstract][Full Text] [Related]
5. A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation.
Qian JY; Zhang F; Fan B; Ge L; Wang QB; Ge JB
Chin Med J (Engl); 2008 Mar; 121(6):498-502. PubMed ID: 18364132
[TBL] [Abstract][Full Text] [Related]
6. Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS).
Kosonen P; Vikman S; Jensen LO; Lassen JF; Harnek J; Olivecrona GK; Erglis A; Fossum E; Niemelä M; Kervinen K; Ylitalo A; Pietilä M; Aaroe J; Kellerth T; Saunamäki K; Thayssen P; Hellsten L; Thuesen L; Niemelä K
Int J Cardiol; 2013 Sep; 168(2):1010-6. PubMed ID: 23164593
[TBL] [Abstract][Full Text] [Related]
7. Intravascular ultrasound assessment of postprocedural incomplete stent apposition.
Kume T; Waseda K; Ako J; Sakata K; Yamasaki M; Shimohama T; Tsujino I; Hasegawa T; Fitzgerald PJ; Honda Y
J Invasive Cardiol; 2012 Jan; 24(1):13-6. PubMed ID: 22210583
[TBL] [Abstract][Full Text] [Related]
8. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
9. [Association between late incomplete stent apposition after sirolimus eluting stent implantation and clinical outcomes in patients with acute coronary syndrome].
Zhang RY; Du R; Zhu ZB; Zhang Q; Hu J; Ding FH; Lü AK; Zhang JS; Shen WF
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):30-4. PubMed ID: 19671348
[TBL] [Abstract][Full Text] [Related]
10. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.
Cook S; Eshtehardi P; Kalesan B; Räber L; Wenaweser P; Togni M; Moschovitis A; Vogel R; Seiler C; Eberli FR; Lüscher T; Meier B; Jüni P; Windecker S
Eur Heart J; 2012 Jun; 33(11):1334-43. PubMed ID: 22285579
[TBL] [Abstract][Full Text] [Related]
11. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
[TBL] [Abstract][Full Text] [Related]
12. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.
Cook S; Ladich E; Nakazawa G; Eshtehardi P; Neidhart M; Vogel R; Togni M; Wenaweser P; Billinger M; Seiler C; Gay S; Meier B; Pichler WJ; Jüni P; Virmani R; Windecker S
Circulation; 2009 Aug; 120(5):391-9. PubMed ID: 19620501
[TBL] [Abstract][Full Text] [Related]
13. Background incidence of late malapposition after bare-metal stent implantation.
Shah VM; Mintz GS; Apple S; Weissman NJ
Circulation; 2002 Oct; 106(14):1753-5. PubMed ID: 12356624
[TBL] [Abstract][Full Text] [Related]
14. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials.
Hoffmann R; Morice MC; Moses JW; Fitzgerald PJ; Mauri L; Breithardt G; Schofer J; Serruys PW; Stoll HP; Leon MB
Heart; 2008 Mar; 94(3):322-8. PubMed ID: 17761505
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
16. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
[TBL] [Abstract][Full Text] [Related]
18. [Frequency and characteristics of incomplete stent apposition during and after sirolimus-eluting stent implantation].
Takeuchi H; Morino Y; Fujibayashi D; Hashida T; Kawamura Y; Tsumuraya N; Okamoto N; Nagaoka M; Ikari Y; Tanabe T
J Cardiol; 2007 Aug; 50(2):111-8. PubMed ID: 17802694
[TBL] [Abstract][Full Text] [Related]
19. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents.
Waseda K; Ako J; Kume T; Fitzgerald PJ; Honda Y
J Invasive Cardiol; 2016 Aug; 28(8):323-9. PubMed ID: 26689416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
